angiogenesis and chronic hypoxic pulmonary hypertension. 
Introduction
Hypoxia is a well recognized stimulus for pulmonary blood vessel remodeling. One mechanism that may account for this effect is a direct action of hypoxia on the expression of specific genes involved in pulmonary artery smooth muscle cell proliferation such as those encoding the serotonin transporter and endothelin (1, 2) . Hypoxia is also a potent stimulus for the expression of angiogenic factors which trigger endothelial cells (3, 4) . Numerous angiogenic factors and cytokines, including VEGF and VEGF receptors, PDGF, acidic and basic FGF, transforming growth factor, angiogenin, and prostaglandin E2, have also been shown to be increased in lungs from experimental hypoxic animals (5, 6) (7) as well as in tissues from patients with chronic hypoxemic lung disease (8) . The physiological or pathological consequences of hypoxia-induced activation of lung angiogenic processes, however, are not completely understood. Pharmacological blockade of VEGF receptors aggravates (9) whereas lung VEGF overexpression by adenovirus mediated gene transfer attenuates development of hypoxic pulmonary hypertension (10) . However, VEGF is only one among various angiogenic molecules which are upregulated during chronic hypoxia (5, 7).
Moreover, VEGF receptors are present not only on endothelial cells but also on lung epithelial cells (11) and monocytes (12, 13) . Finally, the regulation of angiogenesis is a complex process which depends upon the local balance between proangiogenic and antiangiogenic molecules.
In the present study, we questioned whether changing the angiogenic set point by inducing lung overexpression of an endogenous angiogenesis inhibitor would alter development of hypoxic pulmonary hypertension.
Angiostatin, a potent naturally occurring inhibitor of angiogenesis generated by proteolysis of plasminogen (14) , is considered as one of the most effective and specific inhibitors of angiogenesis. It inhibits proliferation and migration of endothelial cells (15, 16) without exerting toxic effects on the quiescent systemic vasculature. Produced by proteolytic cleavage, angiostatin has been shown to be a 38-kDa internal fragment of plasminogen which consists of four kringle structures. Kringle 1-3 exerts a potent inhibitory effect on endothelial cell proliferation whereas kringle 4 is relatively ineffective (16) .
In the present study, angiostatin delivery was achieved by a defective adenovirus expressing a secretable angiostatin K3 molecule driven by the cytomegalovirus promoter (Ad.K3). We first evaluated the efficiency of gene transfer in the lungs from mice with a single intratracheal instillation of the adenovirus by detecting the protein in bronchoalveolar lavage (BAL) fluid. We also evaluated, in vitro, the consequence of angiostatin expression on the migration and proliferation of microvascular endothelial cells and pulmonary artery smooth muscle cells. In the second part of the study, we evaluated the effect of lung angiostatin expression on pulmonary vascular density and development of pulmonary hypertension in mice pretreated with intratracheal administration of Ad.K3 two days before the start of a two-week exposure to either normoxia or hypoxia.
The samples were run in a 10% SDS polyacrylamide gel before being transferred onto a nitrocellulose membrane. As a control, 100 ng of human plasminogen (Plg) was run. After a one hour incubation in a blocking buffer (TTBS, BSA 5%), the membranes were incubated for one hour with anti-human Plg, and one hour with a horseradish peroxidase conjugated goat anti-mouse serum. After washing, the membranes were revealed by chemiluminescence using the ECL Plus kit (Amersham).
Cell proliferation
The microculture tetrazolium (MTT) assay was used to evaluate the effect of the adenoviral constructs on PA-SMC and HMEC-1 proliferation. Pulmonary artery-SMCs and HMEC-1 were plated at a density of 5. MTT (0.2mg/mL) was added to each well which was incubated for 4 hours at 37°C.
Thereafter, the culture medium was removed and the MTT contained in cells was dissolved by adding 100 µL of DMSO. The extent of reduction of tetrazolium salt to formazan within cells was then quantified spectrophotometrically at 520 nm and taken as an indicator of cell viability.
Cell migration assay
The cell migration assay was adapted from Planus et al (18) : HMEC-1 or PA-SMCs were subjected to growth arrest in medium containing 0.2 % FCS and infected with Ad.K3.
Control cells were not infected, or infected with Ad.CO1 at the same dose. After 72 hours, cells were resuspended at 40.10 6 cells/ml in culture medium containing 15 % FCS and 0.3% agarose and maintained at 37°C to prevent setting of the agarose. Three µl drops of the cellular suspension were plated in the center of each well of a 24-well tissue culture plate. Wells used for migration assay were precoated with type I collagen (0.5mg/mL, Collaborative Biomedical Products) for HMEC-1 and with poly-DL-ornithine (0.5µg/ml, Sigma) for PA-SMCs. The preparation was placed at 4°C for 20 minutes to allow the agarose to gel. Then, 0.5 ml of medium was added to cover the drops. The preparation was incubated at 37°C in 5 % CO 2 for image-analysis software (Perfect Image). This allowed calculation of the cell migration under each condition.
In vivo angiostatin expression

Animals and delivery of adenovirus vectors to the lungs
Male C57BL/6J mice (20 -25 grams body weight) were used for all studies. All animal care
and procedures were in accordance with institutional guidelines. Ad.K3 or Ad.CO1 as the control, was diluted before use with sterile saline, pH 7.4, in a final volume of 50 µl. Mice were anesthetized with intraperitoneal ketamine (7 mg/100 g) and xylazine (1 mg/100 g).
Intratracheal instillation of 50 µl/mouse of diluted Ad.K3 or Ad.CO1 was performed using a standard procedure, as previously described (10) .
Human angiostatin protein detection in bronchoalveolar lavage fluid (BAL)
To evaluate gene transfer efficiency, human angiostatin protein was assessed by western blot analysis in BAL fluid from normoxic mice five days after administration with various doses of Ad.K3 (10 8 to 10 9 pfu) and 5, 10, and 15 days after administration of Ad.K3 or Ad.CO1 at 10 9 pfu.
After intraperitoneal administration of pentobarbital (6 mg/100 g), BAL was performed immediately after blood sampling. A total of 2 ml of warm PBS was used for each mice.
Then, the supernatants of BAL samples spun at 2000 rpm, 4°C, for 15 min, were stored at -20°C.
Histologic evaluation of inflammation after gene transfer
To evaluate the inflammatory response after adenovirus administration, histologic examination was also performed in normoxic mice 4 days after administration with Ad.K3 or Ad.CO1 (10 8 and 10 9 pfu).
Immediately after BAL, the lungs were removed and fixed by infusion of neutral buffered formaldehyde into the trachea. After routine processing and paraffin embedding, multiple sections from each lobe were stained with hematoxylin and eosin. The inflammatory response was analyzed using a previously described empiric semi-quantitative scale based on inflammatory cell type and location (alveoli, bronchi, blood vessels) and on presence of edema and hemorrhage. Epithelial damage in bronchi, bronchioles, or alveoli was scored 0-4 (absent to severe). Extension of inflammation was also scored 0-4 as follows: 0, none; 1, small patchy areas involved; 2, < 10%; 3, 10-50%; 4, > 50% of section area.
Effect of angiostatin expression on development of hypoxic pulmonary hypertension
To examine the effect of angiostatin expression on the pulmonary circulation of normoxic mice and development of hypoxic pulmonary hypertension, Ad.K3 or Ad.CO1 (10 9 pfu) were administered intratracheally two days before the beginning of exposure to normoxia or hypoxia. Hemodynamic measurements and assessment of right ventricular hypertrophy and pulmonary vascular remodeling were performed. In each mouse, a total of 40 intraacinar vessels accompanying either alveolar ducts or alveoli were analyzed by an observer blinded to the treatment. Each vessel was categorized as nonmuscular (no evidence of any vessel wall muscularization), partially muscular (SMCs identifiable in less than three-fourths of the vessel circumference), or fully muscular (SMCs in more than three-fourths of the vessel circumference). Muscularization was defined as the presence of typical SMCs stained red with phloxin, exhibiting an elongated shape and squareended nucleus, and bound by two orcein-stained elastic laminae. The percentage of pulmonary vessels in each muscularization category was determined by dividing the number of vessels in that category by the total number counted in the same experimental group.
Effect of angiostatin expression on pulmonary vascular density
To assess the consequence of angiostatin expression on pulmonary vascular density in various oxygenation conditions, mice were pretreated with Ad.K3 or Ad.CO1. 
Effect of angiostatin on eNOS lung expression
Immediately after removal, the lungs were quickly frozen in liquid nitrogen. After thawing at 0°C, the tissues were sonicated in 0.1 mM phosphate-buffered saline (PBS) containing antiproteases (1µM leupeptin and 1µM pepstatin A) and the detergent CHAPS (20 mmol/L). The homogenate was centrifuged at 3000 g for 10min at 5°C. The supernatants were subjected to SDS-polyacrylamide gel electrophoresis. Proteins in the gel were transferred to a nitrocellulose membrane by electroblotting in a transblot BioRad transfer apparatus, for 12 h at 4°C. Prior to the transfer, the gels, Whatman filter paper, and nitrocellulose membrane were 
Apoptosis assay
Apoptotic cells within the section from lung of mice exposed to normoxia or hypoxia after pretreatment with Ad.K3 or Ad.CO1 were detected by a kit using a terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling method (TUNEL, Boehringer Mannaheim). The apoptotic index was assessed on hematoxylin-eosin-stained histologic sections by counting nuclear and/or cytoplasmic features characterizing the apoptotic process. After image capture, apoptotic features were pointed on the screen and scored using an image analysis system (Perfect Image; Clara Vision, Orsay, France). The apoptotic index was defined as the ratio of this count over the total number of lung cells.
Counts were determined in successive fields when fewer than 100 cells were present in a single field.
Statistical analysis
All results are expressed as means ± SEMs. A two-way ANOVA was performed to compare the effect of Ad.K3 versus Ad.CO1 pretreatment in normoxic and hypoxic mice followed when interaction was significant by non parametric Mann-Whitney test to compare
Ad.K3 and Ad.CO1 pretreatment in each condition of oxygenation. To compare the degree of pulmonary vessel muscularization in two groups of mice, vessels were ordinally classified as nonmuscular, partially muscular, and muscular. Comparison of muscularization between two groups in each condition of oxygenation was performed using a nonparametric Mann-Whitney test.
Results
Evaluation of in vitro gene transfer
As shown in Fig.1 , transduction of HMEC-1 by Ad.K3 induced an accumulation of angiostatin protein in the culture media in a dose-dependent manner, whereas no signal was detected after infection with Ad.CO1. Angiostatin protein was detectable on day 2 and expressed over more than 6 days (Fig.1) .
Effect of angiostatin expression on HMEC-1 and PA-SMCs migration
Four days after transfection with Ad.K3 (10-300 pfu/cell), there was a dose-dependent reduction of HMEC-1 migration which was completely abolished at 300 pfu/cell. No alteration of HMEC-1 migration was observed after treatment with Ad.CO1 ( Fig. 2A) .
However, incubation of PA-SMCs in the presence of Ad.K3 did not alter their migration. As shown in Fig. 2B , cell migration out of the agarose drop explant was similar in PA-SMCs treated with Ad.K3, Ad.CO1 or untreated cells.
Effect of angiostatin expression on HMEC-1 and PA-SMCs proliferation
HMEC-1 infected with Ad.K3 (50 -300 pfu / cell) showed a slight reduction in the growth response to 10% FCS which became significant only at the highest dose (Fig. 3A) .
This effect was not observed in the presence of Ad.CO1, the control construction. However, in PA-SMCs infected with Ad.K3, the proliferation index was not altered and was maintained at levels similar to those measured in the presence of Ad.CO1 (Fig. 3B) .
Evaluation of in vivo gene transfer in normoxic mice
Dose-dependent protein expression and inflammatory response after adenovirus administration
After intratracheal administration of Ad.K3 (10 9 pfu) in normoxic mice, detectable amounts of angiostatin protein were found at day 5 ( Fig. 4) but not at day 10 and 15 after treatment After treatment with Ad.CO1 (10 9 pfu), no human angiostatin was detected in BAL fluid. With 10 9
pfu of either Ad.K3 or Ad.CO1, inflammation was characterized by patchy infiltrates of mononuclear cells, most of which were macrophages. Cell damage, edema or hemorrhage was unfrequent (Table 1) . On the basis of this experiment, 10 9 pfu was the dose selected for further experiments since it caused minimal inflammatory response but significant human angiostatin protein production in lungs.
Effect of angiostatin expression on chronic hypoxic pulmonary hypertension Hemodynamic measurements and assessment of right ventricular hypertrophy
Under normoxic conditions, body weight, RVSP, heart rate and RVweight over either body weight or LV+S weight were similar in Ad.CO1 and Ad.K3 treated animals ( Fig. 5) and were similar to values previously reported in normoxic mice.
As compared to mice maintained under normoxic conditions, animals exposed to 10% O 2 during 15 days exhibited a significant increase in RVSP and development of right ventricular hypertrophy. However, under chronic hypoxic condition, RVSP and right ventricular hypertrophy as assessed by RV/LV+S weight were higher in mice pretreated with
Ad.K3 than in those given Ad.CO1 (P< 0.05 and P<0.01 respectively) whereas left ventricular weight, hematocrit and heart rate did not differ between the two hypoxic groups.
Structural remodeling of distal pulmonary vessels
In mice exposed to normoxia for 15 days following adenovirus administration, muscularization of distal vessels did not differ between Ad.K3 and Ad.CO1 treated animals and were similar to values previously reported in normoxic mice (data not shown). After 15 days of exposure to hypoxia, muscularization of distal vessels which was markedly increased as compared with normoxic animals, was also more marked in Ad.K3 than in Ad.CO1-pretreated mice exposed to similar hypoxic conditions (Fig. 6, P<0 .01).
Effect of hypoxia and angiostatin expression on vascular density
Vascular density was assessed by quantifying the surface area per field that scored immunoreactive for Von Willebrand factor and CD31. As shown in Fig. 7 and Fig. 8A there was an increase of vascular density in the lungs from mice chronically exposed to hypoxia as compared with similarly pretreated normoxic animals (P<0.001). Pretreatment with Ad.K3
significantly reduced lung vascular density in both normoxic and chronically hypoxic mice as compared with controls Ad.CO1 mice (P<0.01) with no significant interaction between oxygenation condition and adenovirus pretreatment (2-way ANOVA).
Effect of hypoxia and angiostatin on eNOS expression
To evaluate the consequences of exposure to hypoxia and treatment with angiostatin on eNOS expression, the levels of eNOS protein were estimated by immunoblotting assay in lungs from mice treated with AdCO1 or with Ad.K3 and maintained under normoxic or hypoxic condition. As shown in Fig. 8B , eNOS protein levels was increased in the lungs from mice chronically exposed to hypoxia as compared with similarly pretreated normoxic animals (P<0.01). Pretreatment with Ad.K3 significantly reduced lung eNOS protein levels in both normoxic and chronically hypoxic mice as compared with controls Ad.CO1 mice (P<0.05) with no significant interaction between oxygenation condition and adenovirus pretreatment (2-way ANOVA).
Effect of angiostatin expression on lung cells apoptosis
Lung sections from mice exposed to normoxia or hypoxia during two weeks and pretreated 
Discussion
The present results show that adenoviral-mediated lung overexpression of the angiogenesis inhibitor, angiostatin, aggravates development of hypoxic pulmonary hypertension in mice. Evidence for an activation of endogenous angiogenic processes in the lung during exposure to hypoxia was highly suggested by the observation that expression of endothelial markers like factor VIII, CD31 and eNOS was increased in chronically hypoxic mice. This change was suppressed by pretreatment with Ad-angiostatin, which also inhibited in vitro endothelial cell growth and migration. Since treatment with Ad-angiostatin did not affect PA-SMCs function in vitro, but potentiated pulmonary hypertension and aggravated structural vascular remodeling in chronically hypoxic mice, the results indicate that counteracting lung angiogenic processes aggravates development of hypoxic pulmonary hypertension.
Hypoxic pulmonary hypertension is the most common form of pulmonary hypertension. Of variable severity, it affects patients of all ages and occurs in subjects who live at high altitude as well as in patients with chronic hypoxemic lung disease. Increased expression of the angiogenic factor VEGF and its receptors has been found in the lung from chronically hypoxic rats (5, 7). In addition to VEGFA, VEGF C and D, other growth factors or cytokines including PDGF, acidic and basic FGF, transforming growth factor, angiogenin, and prostaglandin E2 have also been shown to increase during exposure to hypoxia (6) suggesting that activation of several lung angiogenic processes contribute to the lung adaptation to chronic hypoxia. In systemic vessels, hypoxia or ischemia induced by occlusion of large systemic arteries results in development of newly formed collateral arteries (19) . In the pulmonary circulation, no such an increase in new vessel formation has been angiographically documented. However, labeling studies in rat have suggested a burst of endothelial cell multiplication in intraacinar arteries at the end of the first week of exposure to hypoxia (20) . In the present study, lung density of factor VIII and CD31 immunostaining was increased in mice exposed to chronic hypoxia. These results suggest that activation of lung angiogenic processes in response to hypoxia is associated with an increased number of endothelial cells in distal pulmonary vessels.
The physiological or pathological consequences of hypoxia-induced activation of lung devoted to specifically understand the role of vascular endothelial growth factor (VEGF). In previous studies, we have shown that adenoviral-mediated overexpression of VEGF in rat lungs attenuates development of hypoxic pulmonary hypertension and that this effect is concomitant to the improvement of endothelial function (10) . In recent studies, inhibition of VEGF receptors through tyrosine kinase inhibitors was shown to cause severe pulmonary hypertension with selection and proliferation of apoptosis-resistant endothelial cells (9) .
Interestingly, inhibition of VEGF receptor tyrosine kinase mediated activity was also shown to decrease alveolization in developing lung and to favor emphysema in the adults (21) . Although these results point out important actions of VEGF in the lung, they did not specifically address the role of lung angiogenic processes during development of pulmonary hypertension. As Among those is angiostatin, a 38-kDa fragment of plasminogen (14) , which has been shown in vitro to inhibit endothelial cell proliferation and in vivo to exhibit potent antitumor and antiangiogenic properties (15, 22, 23) . Although its mechanism of action is not completely understood, numerous studies indicate that angiostatin is a highly specific angiogenesis inhibitor. In the present study, angiostatin delivery was achieved by a defective adenovirus expressing a secretable angiostatin K3 molecule from the cytomegalovirus promoter (Ad.K3).
We found that angiostatin gene transfer in cultured endothelial cells inhibited cell migration and partially reduced cell proliferation. These results are consistent with those reported by studies using angiostatin protein. No cytotoxic or apoptotic effect was observed in vitro. More importantly, the effects of angiostatin appeared specific for endothelial cells since human pulmonary artery smooth muscle cells treated with Ad.K3 remained functionally unaltered.
In vivo studies revealed that adenoviral transfer allowed efficient local overexpression of angiostatin in mice lungs. After intratracheal administration of Ad.K3, the angiostatin protein was detected in BAL fluid for about 6 days, with a concentration peak on 4 th day. No angiostatin was detectable in the serum with this low dose of adenovirus, suggesting that angiostatin diffusion or expression in other organs was minimal.
As shown by our histologic study, administration of Ad.K3 or Ad.CO1 caused only mild inflammation in lungs from both normoxic and hypoxic mice. Only small patchy area of macrophage infiltrates were observed, with no epithelial cell damage, edema, or hemorrhage.
The main finding from our study is that angiostatin overexpression in lung tissue from mice exposed to chronic hypoxia aggravated the development of pulmonary hypertension and right ventricular hypertrophy. The development of hypoxic pulmonary hypertension is In conclusion, exposure to chronic hypoxia is associated with the activation of endogenous lung angiogenic processes which attenuate the severity of pulmonary hypertension. This counteracting mechanism may not be found in other models of pulmonary hypertension and may explain why hypoxic pulmonary hypertension is reversible and usually less severe than other forms of the disease. Moreover, they provide further support to the concept that stimulation of angiogenesis in the lung may be viewed as a therapeutic approach of pulmonary hypertension. or Ad.K3 (10 9 pfu) and exposed to normoxia or chronic hypoxia during two weeks. n= 5 animals were studied in each group. Both lung CD31 and eNOS expression were significantly increased after hypoxia as compared with normoxia (P<0. 001 and P<0.01, respectively) but decreased after Ad.K3 pretreatment as compared with Ad.CO1 (P<0.01 and P<0.05, respectively) with no interaction between oxygenation conditions and adenoviral pretreatment Edema, hemorrhage, and epithelial damage were scored from 0 to 4 (none to severe). Ad.CO1 Ad.K3 
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